Insmed Incorporated (INSM)
INSM · Health Care · 
United States
Insmed Incorporated (INSM) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.35%. Anyone who holds an ETF containing Insmed Incorporated also has an indirect stake in the company.
Data and Charts: Insmed Incorporated
Key Data for Insmed Incorporated
Insmed Incorporated Stock Price Chart
The Insmed Incorporated chart shows daily closing prices and is set to the current year by default. The stock is down 35.3% year to date and down 42.0% over twelve months. The last recorded close on October 30, 2026, was $112.58, at 17% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Insmed Incorporated Stock Performance
| Year to date | -35.3% | 1 year | -42.0% |
|---|---|---|---|
| 1 month | -1.4% | 3 months | +14.2% |
| Calendar year 2025 | +152.1% |
Measured in euros, Insmed Incorporated is down 32.0% year to date and down 40.1% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Insmed Incorporated
What ETF Is Insmed Incorporated In?
Insmed Incorporated has above-average ETF coverage and is held by 16 of the 104 ETFs we track, which together follow 7 indices. That puts the stock in more ETFs than 75.8% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 0.35% | €3.51 |
| SPFS | MSCI World Health Care | 0.26% | €2.64 |
| XDWH | MSCI World Health Care | 0.26% | €2.60 |
| XD9U / XD9D | MSCI USA | 0.04% | €0.35 |
| EUNL | MSCI World | 0.03% | €0.30 |
| XDWD / XDWL | MSCI World | 0.03% | €0.25 |
| SWWD | MSCI World | 0.02% | €0.24 |
| SPPW | MSCI World | 0.02% | €0.24 |
| SPYY | MSCI ACWI | 0.02% | €0.23 |
| WIMI | MSCI World IMI | 0.02% | €0.23 |
| IUSQ | MSCI ACWI | 0.02% | €0.20 |
| SPYI / SPSA | MSCI ACWI IMI | 0.01% | €0.12 |
The last column shows how much of €1,000 in one of these funds goes to Insmed Incorporated, based on each fund's latest holdings list.
US-listed ETFs holding Insmed Incorporated (weight per latest SEC filing): ONEQ 0.06%, VUG 0.05%, VTI 0.03%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Insmed Incorporated overlaps with the rest of a portfolio.
Which Tracked Investors Hold Insmed Incorporated?
Insmed Incorporated is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. Of the 2 tracked managers holding the stock, 2 added.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Duquesne Family Office | 1,424,690 | $152M | increased by 270,600 |
| Bridgewater Associates | 455,392 | $49M | increased by 159,813 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to Insmed Incorporated
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Insmed Incorporated | – | – | -42.0% | 54.9% | -210.5% | +66.7% |
 Medline | 16 | – | – | 43.8% | 4.1% | +11.5% |
 Natera | 16 | – | +114.4% | 46.7% | -9.0% | +35.9% |
| Neurocrine Biosciences | 16 | – | +5.8% | 36.2% | 16.7% | +21.4% |
 Roivant Sciences | 16 | – | +88.5% | 39.4% | -3,629.2% | -71.6% |
 Revolution Medicines | 16 | – | +225.0% | 56.2% | – | – |
 United Therapeutics Corporation | 16 | – | +32.0% | 41.2% | 41.9% | +10.6% |
 Royalty Pharma Plc | 16 | – | +81.9% | 23.4% | 32.4% | +5.1% |
 Boston Scientific Corporation | 16 | – | -58.3% | 30.9% | 14.4% | +19.9% |
These stocks reach a portfolio through largely the same funds as Insmed Incorporated. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Insmed Incorporated
Insmed Incorporated Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 0.3 | -0.7 | -245.6% |
| FY ended Dec 2024 | 0.4 | -0.9 | -251.2% |
| FY ended Dec 2025 | 0.6 | -1.3 | -210.5% |
Technical Analysis: Insmed Incorporated
Insmed Incorporated Risk Metrics
The close on Oct 30, 2026, was 46.7% below the highest close since Aug 12, 2024. That high was reached on Dec 1, 2025. When the S&P 500 rose or fell 1%, Insmed Incorporated moved 0.43% on average in the same direction (past 252 trading days). The correlation of 0.09, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Insmed Incorporated.
What Insmed Incorporated Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| CTSI | +0.58 | |
| WPP plc | +0.53 | |
| HFT | +0.50 | |
| HYPE | +0.49 | |
| Millicom International Cellular SA | +0.47 | |
| Motorola Solutions Inc. | +0.45 | |
| Peloton Interactive Inc. Class A | -0.48 | |
| Datadog Inc. Class A | -0.44 | |
| Celsius Holdings Inc. | -0.42 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
